These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32893192)

  • 1. Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health records.
    Ravindrarajah R; Reeves D; Howarth E; Meacock R; Soiland-Reyes C; Cotterill S; Whittaker W; Heller S; Sutton M; Bower P; Kontopantelis E
    BMJ Open; 2020 Sep; 10(9):e040201. PubMed ID: 32893192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis.
    Ravindrarajah R; Sutton M; Reeves D; Cotterill S; Mcmanus E; Meacock R; Whittaker W; Soiland-Reyes C; Heller S; Bower P; Kontopantelis E
    PLoS Med; 2023 Feb; 20(2):e1004177. PubMed ID: 36848393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age- and deprivation-related inequalities in identification of people at high risk of type 2 diabetes in England.
    Watkinson R; McManus E; Meacock R; Sutton M
    BMC Public Health; 2024 Aug; 24(1):2166. PubMed ID: 39127639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014.
    Mathur R; Bhaskaran K; Edwards E; Lee H; Chaturvedi N; Smeeth L; Douglas I
    BMJ Open; 2017 Feb; 7(2):e014444. PubMed ID: 28246144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world study of the multimorbidity and health service utilisation among individuals with non-diabetic hyperglycemia and type 2 diabetes mellitus in North West London.
    Dattani R; Ul-Haq Z; Shah M; Kamalati T; Pierce B; Lucas A; Baruwa A; Bickford-Smith L; Chilcott J; Griffiths T; Frankel AH; Willis T; Tam FWK
    BMJ Open Diabetes Res Care; 2024 Aug; 12(4):. PubMed ID: 39122365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic disparities in non-diabetic hyperglycaemia and the transition to type 2 diabetes: evidence from the English Longitudinal Study of Ageing.
    Chatzi G; Mason T; Chandola T; Whittaker W; Howarth E; Cotterill S; Ravindrarajah R; McManus E; Sutton M; Bower P
    Diabet Med; 2020 Sep; 37(9):1536-1544. PubMed ID: 32531074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.
    Sharma M; Nazareth I; Petersen I
    BMJ Open; 2016 Jan; 6(1):e010210. PubMed ID: 26769791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of body mass index at diagnosis of diabetes in a multi-ethnic population: A case-control study with matched non-diabetic controls.
    Paul SK; Owusu Adjah ES; Samanta M; Patel K; Bellary S; Hanif W; Khunti K
    Diabetes Obes Metab; 2017 Jul; 19(7):1014-1023. PubMed ID: 28211609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data.
    Coles B; Khunti K; Booth S; Zaccardi F; Davies MJ; Gray LJ
    BMJ Open; 2020 Oct; 10(10):e037937. PubMed ID: 33099496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.
    Griffin SJ; Bethel MA; Holman RR; Khunti K; Wareham N; Brierley G; Davies M; Dymond A; Eichenberger R; Evans P; Gray A; Greaves C; Harrington K; Hitman G; Irving G; Lessels S; Millward A; Petrie JR; Rutter M; Sampson M; Sattar N; Sharp S
    Health Technol Assess; 2018 Apr; 22(18):1-64. PubMed ID: 29652246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.
    de Jong RGPJ; Peeters PJHL; Burden AM; de Bruin ML; Haak HR; Masclee AAM; de Vries F; Janssen-Heijnen MLG
    Cancer Epidemiol; 2018 Jun; 54():104-111. PubMed ID: 29705628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].
    Yang XY; Zhang M; Luo XP; Wang JJ; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Zhang HY; Zhou JM; Han CY; Zhao Y; Feng TP; Hu DS; Zhao JZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):328-33. PubMed ID: 27029364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of referral to an open-group behavioural weight-management programme on the relative risk of normoglycaemia, non-diabetic hyperglycaemia and type 2 diabetes: Secondary analysis of the WRAP trial.
    Ahern AL; Griffin SJ; Wheeler GM; Sharp SJ; Aveyard P; Boyland EJ; Halford JCG; Jebb SA
    Diabetes Obes Metab; 2020 Nov; 22(11):2069-2076. PubMed ID: 32618385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could diabetes prevention programmes result in the widening of sociodemographic inequalities in type 2 diabetes? Comparison of survey and administrative data for England.
    Chatzi G; Whittaker W; Chandola T; Mason T; Soiland-Reyes C; Sutton M; Bower P
    J Epidemiol Community Health; 2023 Sep; 77(9):565-570. PubMed ID: 37353312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink.
    Gamble JM; Chibrikov E; Midodzi WK; Twells LK; Majumdar SR
    BMJ Open; 2018 Oct; 8(10):e023830. PubMed ID: 30297350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between preterm delivery and subsequent maternal risk of hypertension and type 2 diabetes mellitus in a UK population-based retrospective cohort study.
    Song A; Okoth K; Adderley NJ
    BMJ Open; 2023 Nov; 13(11):e078167. PubMed ID: 38000828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.
    Hopkins R; Young KG; Thomas NJ; Godwin J; Raja D; Mateen BA; Challen RJ; Vollmer SJ; Shields BM; McGovern AP; Dennis JM
    BMJ Open; 2024 Jan; 14(1):e078135. PubMed ID: 38296292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.
    Wang SY; Andrews CA; Herman WH; Gardner TW; Stein JD
    Ophthalmology; 2017 Apr; 124(4):424-430. PubMed ID: 27914837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.